New Drug Combination Improves Survival in Patients with Muscle-Invasive Bladder Cancer

New treatment approach could help people with muscle-invasive bladder cancer live longer

A new treatment approach could help people with an aggressive form of bladder cancer live longer and reduce the chances of their cancer returning or progressing, particularly those who cannot receive standard chemotherapy, according to findings from a large international clinical trial co-led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center.

New drug combination improves survival in patients with muscle-invasive bladder cancer

A new treatment approach could help people with an aggressive form of bladder cancer live longer and reduce the chances of their cancer returning or progressing, particularly those who cannot receive standard chemotherapy, according to findings from a large international clinical trial co-led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center.

Pre-surgery drug combo cuts death risk in bladder cancer

A large international trial shows that combining immunotherapy and a targeted drug before surgery reduces the risk of death by 42% in bladder cancer patients who cannot receive standard chemotherapy.